It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.
While pharma companies are embracing the transition to digital, and investing significantly in their new products, only 4% of senior executives agree that their digital product launches are
One of the most salient topics in the United States right now in pharma is market access and drug affordability, and one thing that’s driving that topic in this moment are the drug pricing